10x Genomics Research and Development Expenses 2018-2025 | TXG

10x Genomics research and development expenses from 2018 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
10x Genomics Annual Research and Development Expenses
(Millions of US $)
2024 $265
2023 $270
2022 $266
2021 $212
2020 $123
2019 $83
2018 $48
2017 $32
10x Genomics Quarterly Research and Development Expenses
(Millions of US $)
2025-06-30 $61
2025-03-31 $64
2024-12-31 $67
2024-09-30 $66
2024-06-30 $63
2024-03-31 $69
2023-12-31 $65
2023-09-30 $67
2023-06-30 $71
2023-03-31 $67
2022-12-31 $64
2022-09-30 $67
2022-06-30 $71
2022-03-31 $64
2021-12-31 $62
2021-09-30 $55
2021-06-30 $53
2021-03-31 $42
2020-12-31 $40
2020-09-30 $30
2020-06-30 $28
2020-03-31 $26
2019-12-31 $28
2019-09-30 $22
2019-06-30 $18
2019-03-31 $15
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.745B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.976B 58.72
Doximity (DOCS) United States $12.734B 56.66
Tempus AI (TEM) United States $12.722B 0.00
Hims & Hers Health (HIMS) United States $9.947B 81.50
IRhythm Technologies (IRTC) United States $5.455B 0.00
Hinge Health (HNGE) United States $4.531B 0.00
Heartflow (HTFL) $2.821B 0.00
Inspire Medical Systems (INSP) United States $2.730B 40.13
Privia Health (PRVA) United States $2.669B 197.73
Phreesia (PHR) United States $1.904B 0.00
Enovis (ENOV) United States $1.773B 9.37
Omnicell (OMCL) United States $1.526B 29.41
Schrodinger (SDGR) United States $1.457B 0.00
Azenta (AZTA) United States $1.384B 60.40
Clover Health Investments (CLOV) United States $1.379B 0.00
Claritev (CTEV) United States $1.184B 0.00
Evolent Health (EVH) United States $1.130B 0.00
Fulgent Genetics (FLGT) United States $0.662B 0.00
Zepp Health (ZEPP) Netherlands $0.542B 0.00
Veradigm (MDRX) United States $0.535B 0.00
Standard BioTools (LAB) United States $0.489B 0.00
Talkspace (TALK) United States $0.454B 135.50
Butterfly Network (BFLY) United States $0.395B 0.00
Carlsmed (CARL) United States $0.369B 0.00
TruBridge (TBRG) United States $0.302B 52.95
Health Catalyst (HCAT) United States $0.260B 0.00
Outset Medical (OM) United States $0.248B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.225B 0.00
Nyxoah SA (NYXH) Belgium $0.210B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
CapsoVision (CV) United States $0.185B 0.00
MDxHealth SA (MDXH) Belgium $0.170B 0.00
CareCloud (CCLD) United States $0.157B 7.13
ImmunoPrecise Antibodies (IPA) Canada $0.122B 0.00
American Well (AMWL) United States $0.112B 0.00
EUDA Health Holdings (EUDA) Singapore $0.085B 0.00
Pulmonx (LUNG) United States $0.076B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.071B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.040B 0.00
Precipio (PRPO) United States $0.025B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Healthcare Triangle (HCTI) United States $0.015B 0.00
PROFUSA (PFSA) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00